Download Files:

Bamlanivimab

SKU T76849-1 mg Category Brand:

Price range: 317 CAD through 1,389 CAD

Products Details

Product Description

– Bamlanivimab, an Anti-Human SARS-CoV-2 monoclonal antibody (mAb), was the first of its kind to receive Emergency Use Authorization (EUA) from the U.S. Food and Drug Administration (FDA) in November 2020 for COVID-19 treatment. However, its authorization was withdrawn in April 2021 due to emerging SARS-CoV-2 variants resistant to the antibody [1].

Web ID

– T76849

Storage Temperature

– -20℃

Shipping

– Blue Ice

CAS Number

– 2423943-37-5

Product type

– Inhibitory Antibodies

Booklet

Disclaimer: All products are for Research use only unless clearly stated otherwise on the product datasheet. Datasheets provided on the website are drafts for reference purpose only and you are requested to always refer to the hard copy included in the kit for your experimentation. Agdia Products are available for delivery only in Canada.

Related Products

Select options
Placeholder
Anti-Spike-RBD mAb Price range: 597 CAD through 1,461 CAD
100 μg500 μg

1000 in stock

Select options
Placeholder
Anti-SARS-80R mAb Price range: 835 CAD through 1,389 CAD
100 μg500 μg

1000 in stock

Select options
Magrolimab
Magrolimab Price range: 275 CAD through 2,528 CAD
1 mg10 mg5 mg

1000 in stock

Read more
Placeholder
Labetuzumab govitecan
Select options
Natalizumab
Natalizumab Price range: 270 CAD through 2,864 CAD
2 mg1 mg5 mg

1000 in stock

My Cart
Wishlist
Recently Viewed
Categories

Request Data Sheet / Safty Data Sheet

Please enable JavaScript in your browser to complete this form.
=

Price Request

Please enable JavaScript in your browser to complete this form.
=

Compare Products (0 Products)
document.addEventListener('elementor/popup/show', function() { if (typeof turnstile !== 'undefined') { document.querySelectorAll('.cf-turnstile').forEach(function(el) { if (!el.dataset.rendered) { turnstile.render(el); el.dataset.rendered = true; } }); } });